Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Prospective Urban Rural Epidemiology Study

for
Cardiovascular Diseases, Risk Factor, Cardiovascular,
Location: Quebec City, Ottawa, Hamilton, Vancouver
Sponsor: Population Health Research Institute

Sex: All

Age: 35 - 70

Code: NCT03225586

Recruiting

Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis

for
Hemoptysis, Haemoptysis, Lung Disease, Pneumonia, Tuberculosis,
Location: Sherbrooke
Sponsor: Université de Sherbrooke

Sex: All

Age: 18+

Code: NCT02913365

Recruiting

Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

for
Hypertension, Cardiovascular Diseases
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 60+

Code: NCT06507657

Early Phase 1, Recruiting

Detecting and Treating High Blood Pressure in Aboriginal Population and Low and Middle Income Countries

for
Hypertension, Cardiovascular Disease, Diabetes
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18 - 70+

Code: NCT02111226

Recruiting

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

for
Pathologic Processes, Diabetes Mellitus,
Location: Metairie LA
Sponsor: C5 Biomedical

Sex: All

Age: 18+

Code: NCT06674980

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

AnovaOS Network Powered Patient Registry

for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc

Sex: All

Age: 18+

Code: NCT05013944

Recruiting

Vascular Lab Resource (VLR) Biorepository

for
Cardiovascular Diseases, Metabolic Disease,
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT05628948

Recruiting

Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )

for
Hypertension, Cardiovascular Diseases, Diabetes
Location: Winston-Salem NC
Sponsor: Wake Forest University

Sex: All

Age: 18 - 70

Code: NCT06375694

Recruiting

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

for
Cardiovascular Diseases, Myocardial Ischemia, Heart Diseases,
Location: New York NY, Minneapolis MN
Sponsor: Fundación EPIC

Sex: All

Age: 18 - 70+

Code: NCT07286578

Recruiting

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

for
Obesity, Cardiovascular Diseases, Hypertension,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04971720

Phase 2, Phase 3, Recruiting

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

for
Myocardial Infarction, Ischemia, Myocardial Ischemia,
Location: Rochester MN, Murray UT
Sponsor: AliveCor

Sex: All

Age: 18+

Code: NCT06271577

Recruiting

Study of the Progression of Chronic Cardiovascular Conditions

for
Cardiovascular Disease (CVD), Heart Failure, Aortic Stenosis,
Location: Chicago IL
Sponsor: Prolaio

Sex: All

Age: 18+

Code: NCT07420907

Recruiting

A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

for
Hypertension, Dyslipidemia, Diabetes Mellitus, Obesity,
Location: Storrs CT, Hartford CT
Sponsor: University of Connecticut

Sex: All

Age: 18 - 64

Code: NCT07238556

Recruiting

Inspire HER: Inspiring the Heart and Emotions for Radical Health

for
Cardiovascular-kidney-metabolic Syndrome,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 30 - 70+

Code: NCT06966258

Recruiting

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

for
Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension,
Location: Foxborough MA, The Bronx NY, Yardley PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07783802

Phase 2, Recruiting

Preventative Screening and Health Coaching in a Food Insecure Population

for
Cardiovascular Disease Prevention, Cardiometabolic Diseases,
Location: Chicago IL
Sponsor: Rush University Medical Center

Sex: All

Age: 40 - 70+

Code: NCT06907524

Recruiting

REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension

for
Hypertension, Aldosterone Disorder,
Location: Oakland CA
Sponsor: Kaiser Permanente

Sex: All

Age: 18+

Code: NCT07780500

Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Sydney, Moncton, Rimouski, Portsmouth NH, Riverhead NY,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase 3, Recruiting

Diabetes and Heart Disease Risk in Blacks

for
Cardiovascular Diseases, Diabetes, Obesity, Hypertension
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 70

Code: NCT00001853

Recruiting

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

for
Hypertension, Atherosclerotic Cardiovascular Disease
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 55

Code: NCT06962488

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial